DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Ciclazindol

Ciclazindol

  • (19) United States (12) Patent Application Publication (10) Pub

    (19) United States (12) Patent Application Publication (10) Pub

  • Comparison of the Effects of Venlafaxine, Paroxetine and Desipramine on the Pupillary Light Reflex in Man

    Comparison of the Effects of Venlafaxine, Paroxetine and Desipramine on the Pupillary Light Reflex in Man

  • 2012 Harmonized Tariff Schedule Pharmaceuticals Appendix

    2012 Harmonized Tariff Schedule Pharmaceuticals Appendix

  • Lactose Intolerance and Health: Evidence Report/Technology Assessment, No

    Lactose Intolerance and Health: Evidence Report/Technology Assessment, No

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • A New Weight-Reducing Drug with Novel Properties DAVID WHEATLEY M.D., F.R.C.Psych

    A New Weight-Reducing Drug with Novel Properties DAVID WHEATLEY M.D., F.R.C.Psych

  • A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum

    A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum

  • WO 2014/115152 Al 31 July 20 14 (31.07.2014) W P O P CT

    WO 2014/115152 Al 31 July 20 14 (31.07.2014) W P O P CT

  • Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists

    Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists

  • (12) United States Patent (10) Patent No.: US 7,855,195 B2 Buntinx (45) Date of Patent: *Dec

    (12) United States Patent (10) Patent No.: US 7,855,195 B2 Buntinx (45) Date of Patent: *Dec

  • (12) Patent Application Publication (10) Pub. No.: US 2002/0010216A1 Rogosky Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2002/0010216A1 Rogosky Et Al

  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

    Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes

  • (12) United States Patent (Lo) Patent No.: �US 8,480,637 B2

    (12) United States Patent (Lo) Patent No.: US 8,480,637 B2

  • Ep 1547650 A1

    Ep 1547650 A1

  • Rana Dadashova

    Rana Dadashova

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

  • Customs Tariff - Schedule

    Customs Tariff - Schedule

  • (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al

    (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al

Top View
  • Pharmaabkommen A1 E
  • Customs Tariff - Schedule Xxi - 1
  • Wo 2007/044693 A2
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0003992 A1 Wong Et Al
  • Pharmaceutical Appendix to the Tariff Schedule 2
  • WO 2014/018563 A2 30 January 2014 (30.01.2014)
  • Letters to the Editor; If Found Suitable, They Will Be Published As Space Allows
  • (12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
  • Table [1]: Definition of Reported Outcomes Study Outcome
  • Pharmaceutical Appendix to the Harmonized Tariff Schedule
  • (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
  • Pharmaceutical Appendix to the Tariff Schedule 2
  • (12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
  • Red Blood Cell K+ Could Be a Marker of K+ Changes in Other Cells Involved in Blood Pressure Regulation
  • Schedule Clxxiii - European Union


© 2024 Docslib.org    Feedback